| Symbol | IYXI |
|---|---|
| Name | INYX, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 10022 United States NY 825 Third Avenue 40th Floor |
| Telephone | (212) 838-1111 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | US |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001114241 |
| Description | Inyx, Inc. develops and acquires niche pharmaceutical products and drug delivery systems for key therapeutic areas, including respiratory and dermatological applications. Additional info from OTC: |